MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (L38645) - R2 - Effective June 02, 2022

This Local Coverage Determination (LCD) has been revised under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Medicare Coverage Database (MCD) Number: L38645

LCD Title: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells

Effective Date: June 02, 2022

Summary of Changes:
Under CMS National Coverage Policy added regulation CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80.1.2 A/B MAC (B) Contacts with Independent Clinical Laboratories.

Visit the Molecular Diagnostic Services (MolDX) webpage to access the  MolDX Medicare Local Coverage Determination from the “Active LCD” Webpage.

Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.

 

Last Updated Jun 02 , 2022